An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer, according to results from a large international trial led by researchers at UCL and the London School of Hygiene & Tropical Medicine (LSHTM). For cervical cancer, 94% of deaths occur in low- and middle-income countries (350,000 women died in 2022). Ra ...